Quantcast

Nanobiotix NBTXR3 clinical trial


#1

A new trial in France for soft tissue sarcoma:

http://www.nanobiotix.com/news/release/nanobiotix-starts-clinical-trial-with-lead-product-nbtxr3/


#2

Nanobiotix has received approval to start the phase II/III trial:

http://www.nanobiotix.com/news/release/nanobiotix-receives-first-approval-to-start-phase-iiiii-registration-trial-in-sts-in-europe/